Page last updated: 2024-11-03

propentofylline and Brain Atrophy, Circumscribed Lobar

propentofylline has been researched along with Brain Atrophy, Circumscribed Lobar in 1 studies

Research Excerpts

ExcerptRelevanceReference
"Propentofylline is a novel therapeutic agent for dementia that readily crosses the blood-brain barrier and acts by blocking the uptake of adenosine and inhibiting the enzyme phosphodiesterase."8.82Propentofylline for dementia. ( Frampton, M; Harvey, RJ; Kirchner, V, 2003)
"Propentofylline is a novel therapeutic agent for dementia that readily crosses the blood-brain barrier and acts by blocking the uptake of adenosine and inhibiting the enzyme phosphodiesterase."4.82Propentofylline for dementia. ( Frampton, M; Harvey, RJ; Kirchner, V, 2003)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Frampton, M1
Harvey, RJ1
Kirchner, V1

Reviews

1 review available for propentofylline and Brain Atrophy, Circumscribed Lobar

ArticleYear
Propentofylline for dementia.
    The Cochrane database of systematic reviews, 2003, Issue:2

    Topics: Aged; Alzheimer Disease; Dementia; Dementia, Vascular; Humans; Neuroprotective Agents; Pick Disease

2003